Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Fibrobiologics Inc FBLG

Healthcare Biotechnology
FibroBiologics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including wound healing, multiple sclerosis, degenerative disc disease, psoriasis and certain cancers, and potential human longevity applications including thymic... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:FBLG)

FibroBiologics Presenting at the ThymUS 2025 Meeting

GlobeNewswire April 29, 2025

FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean

GlobeNewswire April 11, 2025

FibroBiologics Unveils New and Expanded Houston Laboratory Space to Pursue Innovation and Breakthroughs in Fibroblast-Based Therapeutics

GlobeNewswire April 8, 2025

FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair

GlobeNewswire April 2, 2025

FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update

GlobeNewswire March 31, 2025

FibroBiologics Announces 2025 Annual Meeting of Stockholders

GlobeNewswire March 27, 2025

FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting

GlobeNewswire March 21, 2025

FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics

GlobeNewswire March 4, 2025

FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic

GlobeNewswire February 27, 2025
View More News ››

Opinion & Analysis (NDAQ:FBLG)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:FBLG)

The share price is moving nicely.

eom
ValuePro - April 26, 2025

I'm in here recently at less than a dollar.

I see growth potential here, similar to an exploration-phase mining company that announces a major discovery. 
ValuePro - April 18, 2025
View more Bullboard ››

Desert Gold Ventures Inc.

Desert Gold Ventures Inc.

Desert Gold Ventures Inc. is a gold exploration and development company which controls the approximately 440 square ...
View More »